CytoMed Therapeutics Limited
General ticker "GDTC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.9M (TTM average)
CytoMed Therapeutics Limited does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 4.5%: low 0.87$, high 0.96$
Factors to consider:
- Total employees count: 28 as of 2022
Short-term GDTC quotes
Long-term GDTC plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | SGD0.51MM | SGD0.07MM | SGD0.32MM |
| Operating Expenses | SGD2.09MM | SGD3.20MM | SGD4.84MM |
| Operating Income | SGD-1.58MM | SGD-3.13MM | SGD-4.52MM |
| Non-Operating Income | SGD-2.56MM | SGD0.55MM | SGD0.59MM |
| Interest Expense | SGD0.05MM | SGD0.02MM | SGD0.02MM |
| R&D Expense | SGD1.59MM | SGD1.91MM | SGD2.18MM |
| Income(Loss) | SGD-4.14MM | SGD-2.58MM | SGD-3.93MM |
| Taxes | SGD0.00MM | SGD-0.05MM | SGD0.00MM |
| Net Income(Loss)* | SGD-4.14MM | SGD-2.52MM | SGD-3.92MM |
| Stockholders Equity | SGD11.28MM | SGD8.96MM | SGD6.54MM |
| Inventory | SGD0.68MM | SGD0.84MM | SGD1.07MM |
| Assets | SGD12.40MM | SGD10.07MM | SGD7.98MM |
| Operating Cash Flow | SGD-3.54MM | SGD-2.71MM | SGD-3.70MM |
| Capital expenditure | SGD0.06MM | SGD1.40MM | SGD0.70MM |
| Investing Cash Flow | SGD-2.73MM | SGD1.13MM | SGD0.93MM |
| Financing Cash Flow | SGD10.92MM | SGD-0.06MM | SGD0.21MM |
| Earnings Per Share** | SGD-0.39 | SGD-0.22 | SGD-0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.